Karen Willard-Gallo

Head, Molecular Immunology Laboratory

Institut Jules Bordet

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Karen Willard-Gallo is the Head of the Molecular Immunology Laboratory at the Institut Jules Bordet in Belgium. Her research focuses on immune responses in cancer, including the characterization of CD8+ T cells in breast cancer and the immune response to viral infections in cancer patients. She has contributed to publications on tumor-infiltrating lymphocytes, T follicular helper cells, and B cell interactions, emphasizing their roles in cancer immunotherapy and patient outcomes.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Sheeba Irshad

King’s College London

UNITED KINGDOM

View details

Mariana Brandão

Institut Jules Bordet

BELGIUM

View details

Jeremy Braybrooke

Honorary Associate Professor

University of Bristol

UNITED KINGDOM

View details

JENS TIJTGAT

Vrije Universiteit Brussel

BELGIUM

View details

Teofila Seremet

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Karen Willard-Gallo

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor CD8+ T Cells in Breast Cancer Implications for Adoptive Cell Therapy

Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer

Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis

Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy

A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma

Characterization of Immunoactive and Immunotolerant CD4+ T Cells in Breast Cancer by Measuring Activity of Signaling Pathways That Determine Immune Cell Function

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.

Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.

B cells and cancer.

Collaborators (5)

Sheeba Irshad

Mariana Brandão

Jeremy Braybrooke

JENS TIJTGAT

Teofila Seremet

Make your next move.